Matt David, M.D.

September 6, 2025

Matt David was appointed Executive Vice President and Chief Business Officer in August 2025. Dr. David also served as CorMedix’s CFO from May 2020 to August 2025 and interim CEO from October 2021 to May 2022. He leads the company’s corporate development, capital markets, and investor relations activities. Prior to joining CorMedix, Dr. David was Head of Strategy at Ovid Therapeutics and spent the majority of his career in healthcare investment banking roles where he advised life sciences companies on a broad range of financing and strategic transactions. Earlier in his career, Dr. David spent time as a research analyst covering the pharma sector. Dr. David received his M.D. from NYU School of Medicine and his undergraduate degree from Dartmouth College.